Madison Asset Management LLC acquired a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 631,763 shares of the medical research company’s stock, valued at approximately $83,917,000. Madison Asset Management LLC owned about 0.22% of Agilent Technologies at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of A. West Family Investments Inc. bought a new stake in shares of Agilent Technologies in the second quarter valued at $622,000. Knuff & Co LLC purchased a new position in shares of Agilent Technologies during the 2nd quarter valued at $203,000. NewEdge Wealth LLC bought a new position in shares of Agilent Technologies during the 2nd quarter worth $668,000. Great Lakes Advisors LLC bought a new position in shares of Agilent Technologies during the 2nd quarter worth $297,000. Finally, Danske Bank A S purchased a new stake in Agilent Technologies in the 2nd quarter worth about $32,556,000.
Wall Street Analysts Forecast Growth
Several research firms have commented on A. Jefferies Financial Group assumed coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective on the stock. TD Cowen boosted their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Barclays boosted their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Finally, Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.
Agilent Technologies Trading Up 4.7%
Shares of Agilent Technologies stock opened at $155.40 on Thursday. The company’s 50-day moving average price is $136.44 and its 200-day moving average price is $125.84. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a market cap of $43.89 billion, a price-to-earnings ratio of 31.20, a PEG ratio of 2.63 and a beta of 1.25.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period last year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.
Agilent Technologies Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Recommended Stories
- Five stocks we like better than Agilent Technologies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
